Published 2 months ago

Sequel's twiist™ Automated Insulin Delivery System Receives FDA 510(k) Clearance

Summary by Ground News

The FDA granted 510(k) clearance for an automated insulin delivery system. The system uses Tidepool Loop technology to automatically adjust insulin delivery based on continuous glucose monitoring readings and predicted glucose levels. Twiist, which was developed by DEKA Research & Development Corp., was designed to offer greater flexibility for users.

0 Articles

All

Left

Center

Right

Benzinga

Sequel's twiist™ Automated Insulin Delivery System Receives FDA 510(k) Clearance

MANCHESTER, N.H., March 18, 2024 (GLOBE NEWSWIRE) -- Sequel Med Tech, LLC, a company developing state-of-the-art insulin delivery technologies, today announced its partner, DEKA Research & Development Corp., has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the innovative twiist™ Automated Insulin Delivery (AID) system powered by Tidepool. The twiist AID system, which will be commercialized by Sequel Med Tech,…

2 months ago·New York, United States

Read Full Article

Healio

FDA clears automated insulin delivery system for children and adults with type 1 diabetes

The FDA granted 510(k) clearance for an automated insulin delivery system that can measure the volume and flow of insulin within every micro-dose, according to an industry press release. The twiist automated insulin delivery system (Sequel Med Tech) was cleared for people aged 6 years and older with type 1 diabetes. Benefiting from the medical device interoperability standards adopted in 2017,

2 months ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center2Last Updated2 months agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Sequel's twiist™ Automated Insulin Delivery System Receives FDA 510(k) Clearance

0 Articles

0 Articles

Sequel's twiist™ Automated Insulin Delivery System Receives FDA 510(k) Clearance

Sequel's twiist™ Automated Insulin Delivery System Receives FDA 510(k) Clearance

FDA clears automated insulin delivery system for children and adults with type 1 diabetes

FDA clears automated insulin delivery system for children and adults with type 1 diabetes

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics